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Abstract: Tripeptidyl-peptidase II (TPPII) is a serine peptidase highly expressed in malignant Burkitt’s lymphoma cells 
(BL). We have previously shown that overexpression of TPPII correlates with chromosomal instability, centrosomal and 
mitotic spindle abnormalities and resistance to apoptosis induced by spindle poisons. Furthermore, TPPII knockdown by 
RNAi was associated with endoreplication and the accumulation of polynucleated cells that failed to complete cell division, 
indicating a role of TPPII in the cell cycle. Here we have applied a global approach of gene expression analysis to gain 
insights on the mechanism by which TPPII regulates this phenotype. mRNA proﬁ  ling of control and TPPII knockdown BL 
cells identiﬁ  ed one hundred and eighty ﬁ  ve differentially expressed genes. Functional categorization of these genes high-
lighted major physiological functions such as apoptosis, cell cycle progression, cytoskeleton remodeling, proteolysis, and 
signal transduction. Pathways and protein interactome analysis revealed a signiﬁ  cant enrichment in components of MAP 
kinases signaling. These ﬁ  ndings suggest that TPPII inﬂ  uences a wide network of signaling pathways that are regulated by 
MAPKs and exerts thereby a pleiotropic effect on biological processes associated with cell survival, proliferation and 
genomic instability.
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Introduction
TPPII is a 138-kDa serine peptidase found in both cytoplasmic and membrane associated oligomeric 
complexes of more than 1000 kDa (Balow et al. 1983; Balow et al. 1986; Geier et al. 1999; Rose et al. 
1996). The assembled enzyme functions as an exopeptidase that removes tripeptides from the free 
N-terminus of polypeptides (Balow and Eriksson, 1987; Balow et al. 1983; Balow et al. 1986; Tomkinson 
et al. 1997), but also exhibits endopeptidase activity towards long peptides (Geier et al. 1999; Seifert 
et al. 2003). We have previously demonstrated that overexpression of TPPII in Burkitt’s lymphoma or 
transfected HEK293 cells correlates with accelerated proliferation and with the accumulation of centro-
some and chromosome aberrations, whereas functional knockdown of TPPII by shRNA results in growth 
retardation and the accumulation of polynucleated cells that fail to complete cell division (Stavropoulou 
et al. 2005). We have also shown that TPPII overexpressing cells evade mitotic arrest induced by spindle 
poisons and display high levels of polyploidy despite the constitutively high expression of major com-
ponents of the spindle checkpoints (Stavropoulou et al. 2006). This was accompanied by up-regulation 
of inhibitors of apoptosis (IAPs) and resistance to p53-induced apoptosis, suggesting that TPPII may 
allow the transit through mitosis and the survival of cells with severe mitotic spindle damage.
Collectively, these ﬁ  ndings suggest that TPPII participates in the regulation of critical events that 
control the homeostasis of cell division. In particular, the accumulation of centrosome abnormalities 
and multipolar spindles, together with the capacity to overcome spindle checkpoints, point to a possible 
involvement of TPPII in the early phases of mitosis, at or around the time of centrosome duplication. 
A growing body of evidence indicates that, apart from its function as microtubule organization center 
(MTOC), the centrosome also serves as a scaffold for multiple signaling networks that control critical 
cellular functions, including the cell cycle, the activation of mitotic checkpoints and stress responses, 254
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through association with key regulators such as 
kinases and motor proteins (Doxsey et al. 2005; 
Hong et al. 2007).
In the present study, we have performed a global 
gene expression proﬁ  ling in cells where TPPII 
expression was silenced by shRNA to identify 
regulatory pathways and cellular functions that are 
affected by modulation of TPPII expression. Com-
putational strategies were then used to correlate 
transcriptional changes with protein function and 
physical interaction data in order to interpret the 
biological activity of the affected cellular path-
ways. Using this approach we have identiﬁ  ed 
signiﬁ  cant changes in the expression levels of 
genes whose products control fundamental cellular 
processes including the cell cycle, apoptosis, signal 
transduction and cytoskeleton remodeling. 
Amongst the affected genes were several compo-
nents of the MAPK signaling pathway.
Materials and Methods
Cell lines
The Epstein-Barr virus (EBV)-positive Burkitt’s 
lymphoma (BL) line Namalwa was established 
from an EBV positive BL biopsy (Klein et al. 
1972). The cells were maintained in RPMI medium 
supplemented with 10% (v/v) fetal calf serum 
(FCS) at 37 °C in a 5% (v/v) CO2 incubator.
Lentiviruses and infection procedure
Recombinant lentiviruses expressing control and 
human TPPII gene speciﬁ  c shRNAs were described 
previously (Stavropoulou et al. 2005). Namalwa 
cells were plated at a density of 0.5 × 10
6 cells/well 
in 6-well plates and were infected with 500 µl of 
virus stock for 2 h at 37 °C in a 5% CO2 incubator 
and then selected in medium containing 5 µg/ml 
puromycin (Sigma-Aldrich, Missouri, U.S.A). 
TPPII protein levels and activity were monitored 
by western blotting and enzymatic assays as 
described earlier (Stavropoulou et al. 2005). More 
than 90% knockdown was usually observed within 
10 days of selection.
RNA isolation
RNA isolation was done according to the Qiagene 
RNAeasy protocol (Qiagene, Valencia, CA, 
U.S.A). Briefly, the cells were washed with 
Phosphate-buffered saline (PBS) and lysed with 
Qiagene solution containing β-mercaptoethanol. 
After puriﬁ  cation on a Qiagene column, the RNA 
was eluted and analyzed for quantiﬁ  cation and 
purity with Agilent 2100 bioanalyzer.
Microarray analysis
High-density oligonucleotide microarrays from 
Affymetrix were used in this study. cDNA was 
synthesized using a T7-linked oligo-dT primer and 
used for cRNA synthesis with biotinylated-UTP 
and CTP. After fragmenting, the labeled RNAs 
were hybridized to HG-U133 Plus 2.0 oligonucle-
otide arrays (Affymetrix Incorporated, Santa Clara, 
CA, U.S.A.) according to the protocol recom-
mended by the supplier. The arrays were then 
washed and developed with streptavidin-
phycoerythrin and biotinylated antibody against 
streptavidin (Molecular Probes Inc., Eugene, OR, 
U.S.A.) in an Affymetrix ﬂ  uidics station. The HG-
U133 Plus 2.0 arrays monitors the expression 
levels of 47000 transcripts of human genes involved 
in a wide spectrum of cellular functions.
Hybridized and developed arrays were scanned 
and the expression values for each probe set were 
calculated using the Affymetrix Microarray Suite 
Software (MAS) version 5.0. Scan quality was 
assured based on a priori quality control criteria, 
including the absence of visible microarray arti-
facts, signiﬁ  cant differences in microarray inten-
sity, and a minimum of 1000 probe sets receiving 
‘Present’ calls. Probe level quality control param-
eters were assessed as indicated in the Affymetrix 
toolbox and the expression data from three repli-
cates were normalized for further analysis.
Normalized probe set data from each pair of 
TPPII knockdown and control cells were com-
pared to ﬁ  nd differentially regulated genes. The 
magnitude and direction of expression changes 
were estimated as Signal Log Ratio (SLR), where 
an SLR of 1.0 corresponds to a 2-fold increase of 
the transcript level while SLR −1.0 corresponds 
to a 2-fold-decrease. Differentially regulated 
genes were classiﬁ  ed into molecular functions 
according to their Affymetrix annotations or 
assigned Gene Ontology (GO) categories (http://
www.geneontology.org/). WEB-based GEne SeT 
AnaLysis Toolkit (WebGestalt) (Zhang et al. 
2005) was used to identify GO categories and 
Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathways that are signiﬁ  cantly enriched 
of differentially regulated genes. Protein-protein 255
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interaction data from Biological General 
Repository for Interaction Datasets (BioGRID) 
version 2.0.31(Stark et al. 2006) were used to infer 
molecular networks involving genes with altered 
expression. Cytoscope version 2.5.1 was used to 
visualize the interaction network (Shannon 
et al. 2003).
Results
Functional knockdown of TPPII 
by shRNA
In order to gain insights on the cellular functions 
that are regulated by TPPII, global gene expression 
analysis was performed in the BL line Namalwa, 
that spontaneously expresses high levels of TPPII, 
and in Namalwa cells where TPPII expression was 
silenced by shRNA. Three independent pairs of 
mRNAs were isolated from cells transduced with 
previously characterized control and TPPII-speciﬁ  c 
shRNA expressing lentiviruses. In each case, the 
efﬁ  ciency of TPPII knockdown was conﬁ  rmed 
before RNA isolation by Western blot analysis 
using a TPPII speciﬁ  c antibody (Fig. 1A) and by 
enzymatic assays of total cell lysates using the 
ﬂ  uorogenic substrate AAF-AMC (Fig. 1B). The 
knockdown was confirmed by analysis of the 
microarrays where the TPPII coding sequence was 
detected with two Probe sets (203374_s_at and 
203375_s_at). TPPII mRNA expression levels 
scored an average of −1.5 SLR (Signal Log Ratio) 
corresponding to 2.8 fold down-regulation.
Microarray data analysis 
and gene ﬁ  ltering
Gene expression profiles were obtained using 
Affymetrix GeneChips HG-U133 Plus 2.0 arrays. 
Microarray data were subjected to quality test and 
then normalized for further analysis. Pair-wise 
comparisons between control and TPPII knock-
down samples were performed between each Probe 
set on one array and its counterpart on the second 
array, and a Difference Call was obtained, indicat-
ing “Increase”, “Decrease” or “No Change”. One 
hundred and fourteen probe sets showing “Increase” 
in all three experiments and 251 “Decrease” 
(Fig. 2A) probes were further ﬁ  ltered based on 
reproducibility between experiments. Probe sets 
showing SLR ≥0.5 or ≤ −0.5 in each experiment 
and standard deviation ≤50% between the three 
experiments were identiﬁ  ed as stringently modu-
lated. Multiple probe sets for the same gene were 
than reduced to one representative probe set. One 
hundred and eighty ﬁ  ve genes displayed signiﬁ  cant 
transcriptional changes upon TPPII knockdown, 
50 were up-regulated and 135 down-regulated 
(Fig. 2B). Cluster analysis was performed to iden-
tify the genes with similar expression patterns. As 
expected, TPPII was found in the cluster of the 
most signiﬁ  cantly down-regulated genes (Fig. 2C). 
Inhibin beta E (INHBE), Plexin C1, Retinoblastoma-
like 2 (p130) and a few hypothetical proteins were 
also present in this cluster. The most down-
regulated gene was INHBE, showing a 6.3 fold 
decrease in TPPII knockdown cells (Fig. 2C). 
Similar levels of downregulation were detected by 
Figure 1. TPPII expression and activity is efﬁ  ciently suppressed by TPPII speciﬁ  c shRNA. A) Representative Western blot illustrating 
the expression of TPPII in untreated Namalwa cells (CTR) and Namalwa cells transduced with lentivirus expressing control (CTR shRNA) 
or TPPII speciﬁ  c shRNAs (TPPII shRNA) after 10 days on puromycin selection. Chicken antibodies speciﬁ  c for TPPII were used for the 
detection. B) Peptidase activity was assessed by cleavage of the ﬂ  uorogenic substrates Ala-Ala-Phe-AMC. Activity is expressed as Relative 
Fluorescence Units (RFU) of free AMC released by incubation for 1 hr at 37 °C in the presence 1 µg of cell lysate.256
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RT-PCR analysis conﬁ  rming the validity of the 
microarray data (not shown). INHBE is a secreted 
protein belonging to the Tumor growth factor-β 
(TGF-β) family and was earlier shown to be 
involved in the regulation of liver homeostasis and 
proliferation of pancreatic exocrine cells 
(Chabicovsky et al. 2003; Hashimoto et al. 2006). 
The cluster of highly up-regulated genes included 
the cytoskeleton regulators Actin like protein 8 
(ACTL8) and Myosin binding protein C1 
(MYBPC1) up-regulated 5.9 and 3.8 fold respec-
tively. Macrophage expressed gene 1 (MPEG1), a 
Mps1 protein family member that participates in 
centrosome duplication and spindle assembly (Fisk 
et al. 2003), was up-regulated 3.6 fold (Supple-
mentary information Table S1).
Functional classiﬁ  cation and gene 
ontology analysis
In order to identify biological functions that are 
affected by the loss of TPPII, the 185 stringently 
modulated genes were classiﬁ  ed into functional 
categories according to their Affymetrix and GO 
annotations (Supplementary information Table S1). 
Genes belonging to similar functional categories 
Figure 2. Statistical analysis of gene expression data. A) Venn diagram demonstrating the number of probe sets “Up-regulated” and 
“Down-regulated” by TPPII knockdown in three independent experiments. B) The probe sets were ﬁ  ltered with cut-off signal log ratios (SLR) 
of ≥0.5 (for up-regulated) or ≤ −0.5 (for down-regulated) and standard deviation (SD) less than 50% between three experiments and a single 
representative probe set was then used. C) TPPII was found in the cluster of highly down-regulated genes with an average of 2.8 fold 
repression.257
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were then clustered to identify the affected 
biological functions (Fig. 3). This functional cat-
egorization revealed that the TPPII affected genes 
belong to families involved in the regulation of 
apoptosis, cell cycle, cytoskeleton, proteolysis, 
signal transduction, immune responses, ion trans-
port and metabolism (Fig. 3). Twenty-seven out of 
185 genes lack functional annotation.
To identify signiﬁ  cantly affected biological 
functions, the GO database was searched using the 
set of differentially regulated genes. The GO Tree 
Machine available within WebGestalt was used to 
associate genes with GO terms. Enrichment of 
genes in each category was evaluated by Fisher’s 
exact test, which assigns a P-value indicating the 
statistical probability of the number of genes 
observed compared to the expected number, and 
categories with P-value 0.05 were identiﬁ  ed as 
significantly affected. Table 1 shows a non-
redundant list of signiﬁ  cantly affected GO catego-
ries found under the Biological Process, Molecular 
Function or Cellular Component branches of the 
GO tree. Biological processes associated with 
cytoskeleton organization, cell cycle, cell death, 
immune responses and metabolism were signiﬁ  -
cantly affected by TPPII knockdown. Under 
Molecular Function the largest number of regulated 
genes was found in categories associated with 
kinase activity, while the Cellular Components 
showed cytoplasmic proteins, particularly proteins 
involved in the microtubule and centrosome 
organization.
KEGG pathway analysis
To identify the molecular events regulated by 
TPPII, affected genes were overlaid onto the 
KEGG pathway database. This analysis identiﬁ  ed 
63 KEGG pathways containing one or more strin-
gently modulated genes. Statistically enriched 
pathways (P-value 0.05) are listed in Table 2. 
Three signal transduction pathways: Mitogen-
activated protein kinase (MAPK) signaling 
(P = 0.0195), Focal adhesion (P = 0.0184) and 
TGF-β signaling (P = 0.028) and some amino acid 
metabolic pathways were found in this group. The 
MAPK signaling pathway is activated by a vari-
ety of extracellular stimuli and regulates a broad 
array of biological processes, including Focal 
adhesion and TGF-β signaling that were signiﬁ  -
cantly affected by TPPII knockdown. Interest-
ingly, many of the kinases of this pathway were 
down-regulated while the phosphatase, Protein 
tyrosine phosphatase, receptor type, R (PTPRR) 
was up-regulated suggesting that multiple events 
cooperate to inactivate the signaling cascade. 
A simpliﬁ  ed scheme of the pathways identiﬁ  ed by 
genes that are differentially expressed upon TPPII 
knockdown is shown in Figure 4.
Protein interaction networks
The annotated molecular interactions of proteins 
encoded by the differentially regulated genes were 
used to interpret the observed transcriptional 
changes in a cellular context. For this analysis we 
took advantage of the human interactome data from 
BioGRID version 2.0.31 that compiles ﬁ  ltered 
protein-protein interactions from all currently 
available databases. Physical interactions are visu-
alized as protein interaction maps, or networks, 
that consist of nodes (circles) symbolizing proteins, 
and edges (lines) representing biological relation-
ship between two proteins.
Mapping of the 185 signiﬁ  cantly affected genes 
onto the BioGRID dataset resulted in a small net-
work of 11 genes including several components of 
the MAPK pathway that was also identiﬁ  ed by the 
KEGG pathway analysis (Fig. 5A). To further 
recognize possible upstream and downstream 
components of the network, we performed a two-
step search aiming to identify regulated genes that 
might have been disconnected due to no change of 
the connecting node. To this end, we ﬁ  rst extracted 
all the interacting partners of the 11 hits mapped 
to the network and then listed all their interactions. 
From the complex network generated by this sec-
ond level search we selected all the hits that were 
signiﬁ  cantly regulated by TPPII knockdown. This 
resulted in the identiﬁ  cation of 9 genes whose 
products are connected to the original network via 
non-regulated intermediates (Fig. 5B). The 20 
interacting proteins identiﬁ  ed by this analysis are 
all members of the MAPK signaling cascade, fur-
ther conﬁ  rming that MAPKs are central hubs in 
the molecular interactions regulated by TPPII.
Discussion
Our earlier observation that overexpression of the 
cytosolic peptidase TPPII in epithelial and lym-
phoid cells correlates with abnormalities of centro-
some and mitotic spindle and with genomic 
instability prompted us to undertake an in depth 
analysis of the role of this enzyme in the regulation 258
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Figure 3. Functional categories of genes affected by TPPII knockdown. A) Functional classiﬁ  cation of the genes that are differentially 
regulated by TPPII knockdown. Heatmap showing modulated genes clustered into speciﬁ  c biological function based on Affymetrix annotation 
and GO classiﬁ  cation. B) Graphical representation of the distribution of modulated genes in to functional groups.259
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Table 2. KEGG pathways that are signiﬁ  cantly enriched with differentially regulated genes upon TPPII 
knockdown.
KEGG pathways No. of genes P-value Up-regulated Down-reguated
Observed Expected
Cell communication
Focal adhesion 5 1.49 0.018 HGF, TTN ITGα6, MAPK1, MAPK8
Signal transduction
Cytokine-cytokine 
receptor interaction
6 1.87 0.012 TNFRSF21, HGF, 
IL7R, IFNα2
CCL22, INHBE
MAPK signaling 6 2.08 0.020 PTPRR ELK4, ZAK, MAPK1, 
MAPK8, RPS6KA3
TGF-beta signaling 3 0.64 0.028 MAPK1, RBL2, INHBE
Metabolism
Citrate cycle 2 0.21 0.022 CS, IDH2
Alanine and aspartate 
metabolism
2 0.23 0.025 ASS1, PDHX
Vitamin B6 metabolism 1 0.03 0.042 PSAT1
Figure 4. Schematic representation of the signaling pathways affected by TPPII knockdown. KEGG pathway analysis of the differentially 
regulated genes demonstrates enrichment of components of the MAPK, Focal adhesion and TGF-β signaling. The annotated relationship 
between the regulated gene products is illustrated as activation (È) or inhibition (┴). Genes that are up- and down-regulated in TPPII 
knockdown cells are indicated by thick and dash-line boarders, respectively.262
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Figure 5. Members of the MAPK signaling cascade act as protein hubs of the interaction networks affected by TPPII knockdown. 
A) Network derived from the binary interactions of the gene products that are differentially regulated by TPPII expression. Proteins are 
represented as nodes (circles) and interactions are represented as connecting edges (lines). Up-regulated and down-regulated genes are 
indicated as nodes with thick and thin borders respectively. B) Extended network including the gene products identiﬁ  ed by the two-step 
search described in the Results section. Non-regulated intermediates are indicated by white circles and are connected to the original network 
by dashed lines.
of the cellular functions. Using a global approach 
based on the identiﬁ  cation of genes affected by 
TPPII knockdown we have now found that TPPII 
is involved in a broad variety of cellular processes, 
including the cell cycle, apoptosis and cytoskeleton 
remodeling, all of which are directly or indirectly 
involved in the regulation of genomic stability. 
These ﬁ  ndings are in line with a recent report 
demonstrating that TPPII knockout mice show 
multiple defects associated with inappropriate 
activation of death programs and cellular senes-
cence (Huai et al. 2008). Our ﬁ  ndings suggest that 
the pleiotropic effect of TPPII involves the regula-
tion of MAPK signaling. Several MAP kinases 
were found to be down-regulated while the PTPRR 
phosphatase, an inhibitor of the pathways, was 
up-regulated in cells transduced with TPPII spe-
ciﬁ  c shRNAs, suggesting that different molecular 
events concur to silence this signaling pathways 
upon TPPII knockdown.
MAPK signaling is activated by Ras-family 
Guanosine triphosphatases (GTPases) and other 
protein kinases, and connects extracellular signals 
to transcription factors and other effectors that 
regulate many cellular programs such as cell pro-
liferation, cell death and cytoskeleton remodeling. 
The activity of small GTPases is in turn regulated 
by Guanine exchange factors (GEFs) and GTPase 
activating proteins (GAPs) that play important 
roles in cell cycle and motility (Pruitt and Der, 
2001). Two Ras GTPase regulators, RAS GTPase 
activating protein-1 (RASA1) and Breakpoint 
cluster region (BCR), which contains both Rho-
GEF and Rho-GAP domains (Boguski and 
McCormick, 1993), were down-regulated by TPPII 
knockdown.
MAPKs are also activated by Src-like protein 
tyrosine kinases, such as Lymphocyte-speciﬁ  c 
protein tyrosine kinase (LCK) (Ettehadieh et al. 
1992) that was found among the gene down-
regulated by TPPII knockdown. Thus, several 
upstream regulators of MAP kinases were affected 
by TPPII silencing.
Two kinases, MAPK1 (Extracellular signal 
regulated kinase-2, ERK2) and MAPK8 (c-Jun 
N-terminal kinase, JNK) appear to act as central 
hubs in the interaction network regulated by TPPII. 
Several downstream effectors of these MAPKs, 
including the transcription factors signal transducer 
and activator of transcription 5B (STAT5B), Tran-
scription factor 3 (TCF3) and CCAAT/enhancer 
binding protein (CEBPβ) were also down-
regulated. Both TCF3 and STAT5B are targets of 
MAPK1 and were earlier shown to be involved in 
lymphocyte development and differentiation (Kee 
et al. 2000; Yao et al. 2006). TCF3 is a basic 263
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helix- loop-helix E2A transcription factor (Zhao 
et al. 2001). Though the function of CEBPβ is more 
complex, it is noteworthy that mammary epithelial 
cells lacking CEBPβ show decreased proliferation 
and increased rate of apoptosis (Robinson et al. 
1998). NR3C1 (nuclear receptor subfamily 3, 
group C, member-1), a glucocorticoid receptor that 
appears to be involved in maintaining cell homeo-
stasis (Revest et al. 2005) is another MAPK-
regulated transcription factor that, under certain 
conditions, may also induce apoptosis (Tolosa et al. 
1998). CEBPβ, STAT5 and NR3C1 were shown 
to associate with ATP-dependent chromatin remod-
eling SWI/SNF complexes (Xu et al. 2007). The 
transcript of one SWI/SNF complex associated 
protein, SMARCA4 (SWI/SNF related, matrix 
associated, actin dependent regulator of chromatin, 
subfamily A, member 4) was also found to be 
down-regulated by TPPII knockdown.
High expression of TPPII is associated with 
centrosome abnormalities and the formation of 
multipolar mitotic spindles in HEK293 and BL 
cells, while knockdown of TPPII in BL cells results 
in the accumulation of polynucleated cells 
(Stavropoulou et al. 2005). The possibility that 
TPPII may affect these phenotypes through regula-
tion of centrosome functions is substantiated by 
our present ﬁ  nding that several known regulators 
of the centrosome cycle, most notably the 
centrosome-associated Polo like kinase-1 (Plk1), 
the pericentriolar material-1 (PCM1) and several 
cytoskeletal components such as dynein II light 
chain and kinesin II, were found amongst the genes 
consistently modulated upon TPPII knockdown. 
Furthermore, up-regulation of cytoskeleton com-
ponents such as ACTL8, TTN and MYBPC1 may 
contribute to the morphological changes and 
increased motility induced by TPPII overexpres-
sion in HEK293 cells.
In conclusion, we have found that TPPII down-
regulation is accompanied by coherent changes in 
the expression levels of genes whose products 
mediate critical cellular functions. Among the 
affected genes are several members of the MAPK 
signaling pathway that is a common regulator of 
the phenotypic effects induced by changes in TPPII 
expression. It remains to be seen how the activity 
of TPPII impacts on the regulation of transcription. 
Previous studies have shown that TPPII is involved 
in antigen processing and is the only cytosolic 
peptidase capable of processing proteasome prod-
ucts longer than 14 residues (Glas et al. 1998; Reits 
et al. 2004; York et al. 2006) but speciﬁ  c protein 
substrates have not been identiﬁ  ed. Based on our 
ﬁ  ndings it is tempting to speculate that those may 
include one or more pleiotropic transcription fac-
tors, with regulators of the MAPK cascade as 
primary candidates. Alternatively, TPPII may also 
target components of the cell cycle, apoptosis or 
cytoskeleton whose deregulation may in turn 
impact on MAPK signaling. The ﬁ  ndings presented 
in this paper should be of value in guiding future 
work aiming to the identiﬁ  cation of TPPII cellular 
substrates.
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